Cetuximab - CISMeF

Preferred Label : Cetuximab;

MeSH definition : A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.;

CISMeF synonym : C225, IMC; IMCC225; C225, MAb;

CISMeF acronym : C225;

DeCS synonym : C225;

MeSH hyponym : erbitux; IMC C225; IMC-C225; MAb C225; C225;

MeSH Related Number : 205923-56-4;

Wikipedia link : https://en.wikipedia.org/wiki/Cetuximab;

Is substance : O;

UNII : PQX0D8J21J;

Details

Origin ID

D000068818;

UMLS CUI

C0995188;

ATC code(s)
- cetuximab [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Cetuximab [NCIt concept]
- Cetuximab (substance) [SNOMED CT concept]
- cetuximab [Substance BNPC]
Currated CISMeF NLP mapping
- Cetuximab [LOINC component]
- Cetuximab [ICD-11 Extension code]
- Cetuximab [SMS substance]
- Cetuximab [Anticorps monoclonal]
- cetuximab [International Nonproprietary Name]
Exact mapping(s) to DCI
- cetuximab [International Nonproprietary Name]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Record concept(s)
- IMC C225 [MeSH concept]
- cetuximab [MeSH concept]
- erbitux [MeSH concept]
Related MeSH Supplementary Concept(s)
- 64Cu-DOTA-cetuximab [MeSH Supplementary Concept]
See also
- ErbB Receptors [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing cetuximab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cetuximab [NCIt concept]
- Cetuximab [LOINC component]
- Cetuximab (substance) [SNOMED CT concept]
- Product containing cetuximab (medicinal product) [SNOMED CT concept]
- cetuximab [ATC Code]
- cetuximab [Substance BNPC]
- cetuximab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- cetuximab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients